• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Perioperative Pharmacologic Considerations in Obesity.

作者信息

Willis Simon, Bordelon Gregory J, Rana Maunak V

机构信息

Department of Physical Medicine and Rehabilitation, MedStar Georgetown University Hospital/National Rehabilitation Hospital, 102 Irving Street Northwest, Washington, DC 20010, USA.

Department of Anesthesiology, Louisiana State University Medical Center, 1542 Tulane Avenue, Room 659, New Orleans, LA 70112, USA.

出版信息

Anesthesiol Clin. 2017 Jun;35(2):247-257. doi: 10.1016/j.anclin.2017.01.010.

DOI:10.1016/j.anclin.2017.01.010
PMID:28526146
Abstract

Obesity has increased in incidence worldwide. Along with the increased number of obese patients, comorbid conditions are also more prevalent in this population. Obesity leads to changes in the physiology of patients along with an altered response to pharmacologic therapy. Vigilant perioperative physicians must be aware of the unique characteristics of administered agents in order to appropriately provide anesthetic care for obese patients. Because of the variability in tissue content in obese patients and changes in pharmacokinetic modeling, a one-size-fits-all approach is not justified and a more sophisticated and prudent approach is indicated.

摘要

相似文献

1
Perioperative Pharmacologic Considerations in Obesity.
Anesthesiol Clin. 2017 Jun;35(2):247-257. doi: 10.1016/j.anclin.2017.01.010.
2
Dose adjustment of anaesthetics in the morbidly obese.病态肥胖患者的麻醉药物剂量调整。
Br J Anaesth. 2010 Dec;105 Suppl 1:i16-23. doi: 10.1093/bja/aeq312.
3
[Anesthesia in obese patients--pharmacokinetic aspects].
Ugeskr Laeger. 1995 Aug 21;157(34):4691-4.
4
Perioperative pharmacology in morbid obesity.病态肥胖的围手术期药理学。
Curr Opin Anaesthesiol. 2010 Aug;23(4):485-91. doi: 10.1097/ACO.0b013e32833b0a8c.
5
Anesthetic and pharmacologic considerations in perioperative care of obese children.肥胖儿童围手术期的麻醉和药理学考虑。
J Clin Anesth. 2018 Mar;45:39-50. doi: 10.1016/j.jclinane.2017.12.016. Epub 2017 Dec 21.
6
Lessons learned in drug development from anesthesia.从麻醉学中汲取的药物研发经验。
Rev Esp Anestesiol Reanim. 2005 Jun-Jul;52(6):311-4.
7
Anesthetic Implications of Obesity and Obstructive Sleep Apnea.肥胖与阻塞性睡眠呼吸暂停的麻醉影响
Annu Rev Nurs Res. 2017 Jan;35(1):17-35. doi: 10.1891/0739-6686.35.17.
8
Perianesthetic Implications and Considerations for Myasthenia Gravis.重症肌无力围麻醉期的影响及注意事项
J Perianesth Nurs. 2019 Feb;34(1):4-15. doi: 10.1016/j.jopan.2018.03.009. Epub 2018 Jul 3.
9
Pharmacokinetic considerations in the obese.肥胖患者的药代动力学考虑因素。
Best Pract Res Clin Anaesthesiol. 2011 Mar;25(1):27-36. doi: 10.1016/j.bpa.2010.12.002.
10
Anesthetic challenges in the obese patient.肥胖患者的麻醉挑战。
J Anesth. 2012 Oct;26(5):758-65. doi: 10.1007/s00540-012-1408-4. Epub 2012 May 6.